Search Results

Effect of treatment regimen of the rheumatoid arthritis patients on the risk of coronavirus disease 2019 by modulating the inflammatory mediators.

• Authors : Bagheri-Hosseinabadi Z; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.; Department of Clinical Biochemistry, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Subjects: COVID-19* ; Arthritis, Rheumatoid*; Humans

• Source: Inflammopharmacology [Inflammopharmacology] 2023 Dec; Vol. 31 (6), pp. 3021-3028. Date of Electronic Publication: 2023 Jul 15.Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study.

• Authors : Cherubini F; Department of Experimental Medicine, University of Tor Vergata, Via Montpellier, 1, 00133, Rome, Italy.; Cristiano A

Subjects: SARS-CoV-2*; COVID-19/COVID-19/COVID-19/*blood ; Leukocyte L1 Antigen Complex/Leukocyte L1 Antigen Complex/Leukocyte L1 Antigen Complex/*blood

• Source: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2021 Jun; Vol. 70 (6), pp. 687-694. Date of Electronic Publication: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9508160 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Predicting Pandemics in a Globally Connected World, Volume 2 : Toward a Multiscale, Multidisciplinary Framework Through Modeling and Simulation

• Authors : Maira Aguiar; Nicola Bellomo; Mark Chaplain

Subjects: Biomathematics; Mathematical modelsMATHEMATICS / Applied

Record details

Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection.

• Authors : Kumar A; COVID-19 Testing facility, CSIR-Institute of Himalayan Bioresource Technology (IHBT), Palampur, Himachal Pradesh, India. .; Sharma A

Subjects: COVID-19 Drug Treatment*; Cytokine Release Syndrome/Cytokine Release Syndrome/Cytokine Release Syndrome/drug therapy ; Humans

• Source: Inflammopharmacology [Inflammopharmacology] 2022 Feb; Vol. 30 (1), pp. 23-49. Date of Electronic Publication: 2022 Jan 20.Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details